Vaccination

This lesson covers vaccination as required by the Edexcel GCSE Combined Science specification (1SC0). You need to understand how vaccines work, the concept of herd immunity, the benefits and risks of vaccination, and the process of vaccine development.

---

What Is Vaccination?

Vaccination is a method of preventing disease by introducing a weakened, inactive or dead form of a pathogen (or parts of it) into the body. This stimulates the immune system to produce antibodies and memory cells without causing the disease.

A vaccine is the substance that is administered (usually by injection, but sometimes orally or as a nasal spray).

---

How Vaccines Work

Vaccines exploit the body's natural immune response, specifically the formation of memory cells:

1. A vaccine containing a harmless form of the pathogen (or its antigens) is administered.
2. The antigens on the pathogen trigger the immune response — lymphocytes recognise the foreign antigens.
3. B lymphocytes are activated, divide and produce antibodies specific to the antigens.
4. Memory cells are formed and remain in the body for a long time (often years or a lifetime).
5. If the person is later exposed to the live, active pathogen, the memory cells recognise the antigens immediately.
6. The secondary immune response is triggered — antibodies are produced rapidly and in large quantities, destroying the pathogen before it can cause disease.
7. The person does not become ill — they are immune.

graph TD
    A["Vaccine administered<br/>contains harmless antigens"] --> B["Immune system<br/>recognises antigens"]
    B --> C["Lymphocytes activated<br/>and divide"]
    C --> D["Antibodies produced<br/>specific to antigen"]
    C --> E["Memory cells<br/>formed and stored"]
    E --> F["Later exposure to<br/>live pathogen"]
    F --> G["Memory cells recognise<br/>antigens immediately"]
    G --> H["Rapid secondary response<br/>large antibody production"]
    H --> I["Pathogen destroyed<br/>before illness occurs"]

Exam Tip: A vaccine does NOT contain antibodies. It contains antigens (or a weakened/dead pathogen). The person's own immune system produces the antibodies. This is a very common misconception that costs marks.

---

Types of Vaccine

Type	Description	Example
Live attenuated	Contains a weakened (attenuated) form of the pathogen that can still replicate but does not cause disease	MMR (measles, mumps, rubella)
Inactivated	Contains pathogens that have been killed by heat or chemicals	Influenza vaccine (some types)
Subunit / component	Contains only specific parts (antigens) of the pathogen, not the whole organism	HPV vaccine
Toxoid	Contains an inactivated toxin (toxoid) produced by the pathogen	Tetanus vaccine

All types work by the same principle — presenting antigens to the immune system to stimulate memory cell production.

---

Herd Immunity

Herd immunity occurs when a high proportion of a population is vaccinated, so that even unvaccinated individuals are protected because the pathogen cannot spread easily.

How Herd Immunity Works

• If enough people in a population are immune (through vaccination), the pathogen has fewer hosts to infect.
• This breaks the chain of transmission — the pathogen cannot spread from person to person.
• People who cannot be vaccinated (e.g. very young babies, elderly people, immunocompromised individuals) are indirectly protected.

graph TD
    subgraph "Low Vaccination Rate"
        A1[Infected] --> A2["Unvaccinated<br/>gets infected"]
        A2 --> A3["Unvaccinated<br/>gets infected"]
        A3 --> A4["Unvaccinated<br/>gets infected"]
    end
    subgraph "High Vaccination Rate — Herd Immunity"
        B1[Infected] --> B2["Vaccinated<br/>immune"]
        B1 --> B3["Vaccinated<br/>immune"]
        B1 --> B4["Unvaccinated<br/>but protected"]
    end

The percentage of the population that needs to be vaccinated for herd immunity varies depending on how contagious the disease is:

Disease	Approximate threshold for herd immunity
Measles	~95%
Polio	~80–85%
Influenza	~75–80%

Exam Tip: Herd immunity protects those who CANNOT be vaccinated, not those who choose not to be. In an exam, emphasise that it protects vulnerable individuals such as babies, the elderly and immunocompromised people.

---

Benefits of Vaccination

Benefit	Detail
Prevents serious illness	Vaccines protect individuals from diseases that could be fatal or cause long-term harm
Herd immunity	Protects vulnerable people who cannot be vaccinated
Eradication of diseases	Widespread vaccination has eradicated smallpox and nearly eradicated polio
Reduces healthcare costs	Preventing disease is cheaper than treating it
Prevents epidemics / pandemics	High vaccination rates stop outbreaks from spreading

---

Risks and Limitations of Vaccination

Risk / limitation	Detail
Mild side effects	Some people experience soreness at the injection site, mild fever or tiredness — these are usually short-lived
Rare allergic reactions	Very rarely, a person may have a severe allergic reaction (anaphylaxis) — this is why vaccinations are given by trained professionals
Not 100% effective	No vaccine provides complete protection for every individual — a small percentage may not develop immunity
Pathogen mutation	Some pathogens (e.g. influenza) mutate rapidly, changing their antigens. This means new vaccines must be developed each year
Do not treat existing infections	Vaccines are preventative — they do not cure someone already infected

---

The Vaccine Development Process

Developing a new vaccine is a long, rigorous process:

Stage	What happens
1. Research	Scientists identify the pathogen and its antigens; candidate vaccines are designed
2. Preclinical testing	Vaccines are tested on cells in the lab (in vitro) and on animals (in vivo) to check safety and whether they produce an immune response
3. Clinical trials — Phase I	Small group of healthy volunteers; tests for safety and side effects; determines appropriate dose
4. Clinical trials — Phase II	Larger group (hundreds); tests effectiveness and monitors side effects
5. Clinical trials — Phase III	Very large group (thousands); compares vaccine with placebo; confirms effectiveness across diverse populations
6. Regulatory approval	Data reviewed by regulatory bodies (e.g. MHRA in the UK); vaccine approved for public use if safe and effective
7. Manufacturing and rollout	Vaccine produced at scale and distributed to the population